Physician profile
Todd S Jarrell
NPI 1215042510
$3,144.17
in general payments reported to CMS, 2019-2025
33 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $308 · 2021: $565 · 2022: $517 · 2023: $736 · 2024: $140 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $832.12 | 2019-2024 | Xtandi, Veozah, Myrbetriq |
| Abbvie INC. | $416.69 | 2019-2023 | |
| Boston Scientific Corporation | $305.18 | 2019-2025 | General - Erectile Dysfunction, Axonics |
| Sumitomo Pharma America, INC. | $230.42 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $175.76 | 2022-2024 | Prolaris |
| Rochester Medical Corporation | $101.05 | 2021 | |
| Endo Pharmaceuticals INC. | $87.65 | 2019-2020 | |
| Axonics, INC. | $85.71 | 2022-2024 | Axonics |
| Dendreon Pharmaceuticals LLC | $81.75 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $67.68 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $65.91 | 2020-2023 | |
| Angiodynamics, INC. | $65.62 | 2022 | |
| Antares Pharma, INC. | $65.26 | 2020-2021 | |
| Immunitybio, INC. | $62.56 | 2025 | |
| Allergan, INC. | $61.73 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $59.97 | 2020-2024 | |
| Caldera Medical, INC | $53.63 | 2023 | Desara |
| Blue Earth Diagnostics | $45.39 | 2021-2023 | |
| 180 Medical, INC. | $29.52 | 2022 | |
| Medtronic, INC. | $29.14 | 2021-2023 | Interstim |
| Urovant Sciences INC | $28.04 | 2021-2022 | |
| Amgen INC. | $23.38 | 2021 | |
| Teleflex LLC | $21.90 | 2023 | Urolift |
| Travere Therapeutics, INC. | $19.46 | 2020-2021 | |
| Abc Home Medical Supply, INC. | $18.75 | 2024 | |
| Aytu Biopharma, INC. | $17.91 | 2019 | |
| Urogen Pharma, INC. | $16.95 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $15.76 | 2023 | |
| Srs Medical Systems, INC. | $13.37 | 2022 | |
| Zyla Life Sciences, INC. | $13.24 | 2019 | |
| Dentsply Ih INC. | $12.74 | 2022 | |
| Medtronic USA, INC. | $11.34 | 2020 | |
| Ambu INC. | $8.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Jarrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.